App-based diabetes education for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests an app-based diabetes education program for people with type 1 diabetes. It aims to see if the app can help you manage your blood sugar levels better using insulin pens and a continuous glucose monitor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 1 diabetes for at least 1 year.
- You are 18 years or older.
- Your most recent HbA1c or glucose management indicator is between 7.5% and 11.5%.
- You take multiple daily insulin injections (at least 30 days).
- You are willing to use the study insulin pens, continuous glucose monitor, and a study iPhone and Apple Watch.
- You are not pregnant, planning pregnancy, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests a mobile app that provides structured education to help teenagers with type 1 diabetes improve their blood sugar control, confidence, and daily self-care habits.
This trial tests a smartphone app that helps people with type 1 diabetes predict their blood sugar and decide how much insulin to take. It may be a good fit if you already use multiple daily insulin injections and a continuous glucose monitor.
This study tests an app called PACTAID that helps adults with type 1 diabetes manage their blood sugar during exercise. You will try three different types of workouts to see how well the app works.
This trial studies a smartphone system that helps people with diabetes decide how much insulin to take. It is for people who use insulin injections or are starting basal insulin, and it uses a continuous glucose monitor to guide dosing.
This study tests a smartphone app designed to help people manage their type 2 diabetes. The app may help you overcome everyday challenges and improve your confidence in managing your blood sugar.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.